Compounds > cgp 42112a
Page last updated: 2024-09-03

cgp 42112a and angiotensin iii

cgp 42112a has been researched along with angiotensin iii in 9 studies

Compound Research Comparison

Studies
(cgp 42112a)		Trials
(cgp 42112a)		Recent Studies (post-2010)
(cgp 42112a)		Studies
(angiotensin iii)		Trials
(angiotensin iii)		Recent Studies (post-2010) (angiotensin iii)
233035628453

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (66.67)18.2507
2000's2 (22.22)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, KL; Felix, D; Ferrario, CM; Imboden, H; Khosla, MC; Montani, B1
Smith, RD1
Baldi, E; Catalioto, RM; Cioni, A; Finetti, G; Maggi, M; Mancina, R; Renzetti, AR; Serio, M1
Smith, RD; Timmermans, PB1
Bihoreau, C; Clauser, E; Conchon, S; Corvol, P; Monnot, C; Sirieix, ME1
Coviello, A; Peral de Bruno, M1
Bagi, EE; Fekete, E; Lénárd, L1
Guethe, LM; Juliano, MA; Martins, AR; Pelegrini-da-Silva, A; Prado, WA; Rosa, E1
Denton, KM; Jones, ES; McCarthy, CA; Widdop, RE1

Reviews

2 review(s) available for cgp 42112a and angiotensin iii

ArticleYear
Human angiotensin receptor subtypes.
    Current opinion in nephrology and hypertension, 1994, Volume: 3, Issue:1

    Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; DNA, Complementary; Gene Library; Humans; Imidazoles; Losartan; Oligopeptides; Pyridines; Receptors, Angiotensin; Tetrazoles

1994
Update on the angiotensin AT(2) receptor.
    Current hypertension reports, 2013, Volume: 15, Issue:1

    Topics: Angiotensin III; Animals; Humans; Kidney; Neuroprotective Agents; Oligopeptides; Receptor, Angiotensin, Type 2

2013

Other Studies

7 other study(ies) available for cgp 42112a and angiotensin iii

ArticleYear
Neurophysiological responses to angiotensin-(1-7).
    Hypertension (Dallas, Tex. : 1979), 1991, Volume: 17, Issue:6 Pt 2

    Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Brain; Electrophysiology; Female; Iontophoresis; Neurons; Oligopeptides; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Inbred WKY; Vasopressins

1991
Identification of atypical (non-AT1, non-AT2) angiotensin binding sites with high affinity for angiotensin I on IEC-18 rat intestinal epithelial cells.
    FEBS letters, 1995, Oct-16, Volume: 373, Issue:3

    Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Binding Sites; Binding, Competitive; Biphenyl Compounds; Cell Line; Epithelium; Imidazoles; Intestinal Mucosa; Intestine, Small; Losartan; Oligopeptides; Peptide Fragments; Pyridines; Rats; Receptors, Angiotensin; Tetrazoles

1995
Identification and characterization of functional angiotensin II receptors in human neuroblastoma cells.
    Regulatory peptides, 1995, Apr-14, Volume: 56, Issue:2-3

    Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Binding, Competitive; Biphenyl Compounds; Calcium; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Imidazoles; Kinetics; Losartan; Neuroblastoma; Oligopeptides; Pyridines; Receptors, Angiotensin; Tetrazoles; Tumor Cells, Cultured; Vasoactive Intestinal Peptide

1995
Synthetic cDNA encoding the rat AT1a receptor: a useful tool for structure-function relationship analysis.
    Biochemical and biophysical research communications, 1994, Mar-30, Volume: 199, Issue:3

    Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Base Sequence; Biphenyl Compounds; CHO Cells; Codon; Cricetinae; DNA, Complementary; Imidazoles; Kinetics; Losartan; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; Oligopeptides; Open Reading Frames; Pyridines; Rats; Receptors, Angiotensin; Restriction Mapping; Saralasin; Signal Transduction; Structure-Activity Relationship; Tetrazoles; Transfection

1994
Effects of angiotensin II antagonists on the contractile and hydrosmotic effect of AT II and AT III in the toad (Bufo arenarum).
    Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology, 1996, Volume: 165, Issue:7

    Topics: Analysis of Variance; Angiotensin II; Angiotensin III; Animals; Antihypertensive Agents; Aorta; Biphenyl Compounds; Bufo arenarum; Dose-Response Relationship, Drug; Drug Interactions; Female; Imidazoles; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Oligopeptides; Osmolar Concentration; Osmosis; Pyridines; Skin; Tetrazoles; Vasoconstrictor Agents

1996
Angiotensin II and III microinjections into the zona incerta influence drinking behavior.
    Brain research, 2003, Jul-11, Volume: 977, Issue:2

    Topics: Angiotensin II; Angiotensin III; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Drinking; Drinking Behavior; Drug Interactions; Imidazoles; Losartan; Male; Microinjections; Oligopeptides; Pyridines; Rats; Subthalamus; Time Factors

2003
Angiotensin III modulates the nociceptive control mediated by the periaqueductal gray matter.
    Neuroscience, 2009, Dec-15, Volume: 164, Issue:3

    Topics: Analgesics; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Disease Models, Animal; Drug Interactions; Efferent Pathways; Glutamyl Aminopeptidase; Losartan; Male; Microinjections; Neural Inhibition; Nociceptors; Oligopeptides; Pain; Pain Measurement; Pain Threshold; Peptides; Periaqueductal Gray; Rats; Rats, Wistar; Receptors, Angiotensin

2009